Genesis Therapeutics: Incyte Corp. partners with Genesis Therapeutics to use AI for drug discovery
The deal between Incyte and Genesis has a potential value of more than $900 million.
Read full article »
Genesis Therapeutics is a California-based biotechnology company that discovers and develops novel medicines for the treatment of devastating conditions.
Read more